A recent study by Xing et al. focused on dermatomyositis, which certainly included some cases of ASS, identified anti-Ro-52 antibodies as a significant risk factor for the development of ILD with an odds ratio of 3.106. This evidence concerns the gene TRIM21 and interstitial lung disease.